Skip to main content

2 Result(s)

within Stefan M. Nidorf Remove this filter Medicine & Public Health Remove this filter Pharmacotherapy Remove this filter

and

  1. No Access

    Article

    Elevations in Creatine Kinase are Not Related to the Choice or Dose of Statins in Patients Taking Colchicine 0.5 mg Daily: Insights from the LoDoCo2 Trial

    Amber van Broekhoven, John W. Eikelboom, Stefan M. Nidorf… in Clinical Drug Investigation (2023)

  2. Article

    Open Access

    The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial

    The Low-Dose Colchicine-2 (LoDoCo2) trial showed that 2–4 years exposure to colchicine 0.5 mg once daily reduced the risk of cardiovascular events in patients with chronic coronary artery disease. The potentia...

    Amber van Broekhoven, Niekbachsh Mohammadnia… in Clinical Drug Investigation (2022)

    Download PDF (1239 KB) View Article